Forward Citations = 1

Loading Chart...

9 inventors (with patents filed for the assignee):

Liqun Chen (4 out of 7 patents)

Xiaoran Han (3 out of 3 patents)

Jing Liu (3 out of 3 patents)

4. Jialiang Wang (2 out of 3 patents)

5. Chengwei Zhang (2 out of 3 patents)

6. Jialiang Wang (1 out of 7 patents)

7. Jing Liu (1 out of 100 patents)

8. Matthew Randolph Lee (1 out of 1 patent)

9. Michael Bruno Plewe (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 12758643 - MODIFIED PROTEINS AND PROTEIN DEGRADERS (2026-10-13),

2. 12410171 - Tropomyosin receptor kinase (TRK) degradation compounds and methods of use (2025-09-09),

3. 12065442 - Tropomyosin receptor kinase (TRK) degradation compounds and methods of use (2024-08-20),

4. 11969472 - Tropomyosin receptor kinase (TRK) degradation compounds and methods of use (2024-04-30),

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#540 in Shanghai

#6,406 in China

Shanghai, China

Cullgen (Shanghai), Inc.

Forward Citations = 1

9 inventors:

Liqun Chen (4 out of 7 patents)

Xiaoran Han (3 out of 3 patents)

Jing Liu (3 out of 3 patents)

4. Jialiang Wang (2 out of 3 patents)

5. Chengwei Zhang (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cullgen (Shanghai), Inc.. Retrieved from https://idiyas.com/company/cullgen-shanghai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]